ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
